Sign Up Today and Learn More About Elligo Health Research Stock
Invest in or calculate the value of your shares in Elligo Health Research or other pre-IPO companies through EquityZen's platform.
Elligo Health Research Stock (ELHR)
Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
About Elligo Health Research Stock
Founded
2016
Headquarters
Austin, TX, US
Industries
Science and Engineering, Health Care, Biotechnology
Elligo Health Research is a healthcare company that revolutionizes the clinical research industry with a novel approach to common trial challenges including patient participation and enrollment, and physician participation. They provide physicians and their patients the opportunity to participate in clinical trials using advanced health care informatics. Improved access to physicians and patients means sponsors reach trial enrollment goals faster, and new products are accelerated to market, benefiting patients everywhere. It brings clinical research to physician practices, accelerating the development of pharmaceutical, biotechnology, and medical device products and therapies. Elligo Health Research was founded in 2016 and is headquartered in Austin, Texas.
Elligo Health Research Management
Leadership team at Elligo Health Research
CEO
John Potthoff
President
Chad Moore
Join now and verify your accreditation status to gain access to:
- Elligo Health Research current valuation
- Elligo Health Research stock price
- Available deals in Elligo Health Research and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Elligo Health Research stock?
Accredited investors can buy pre-IPO stock in companies like Elligo Health Research through EquityZen funds. These investments are made available by existing Elligo Health Research shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Elligo Health Research stock?
Shareholders can sell their Elligo Health Research stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
